Soranib Tablet (Sorafenib 200mg) – Liver, Kidney & Thyroid Cancer Treatment
Soranib (Sorafenib) (generic equivalent to Nexavar) is a prescription targeted oncology medication for the treatment of hepatocellular carcinoma (liver cancer), renal cell carcinoma (kidney cancer), and differentiated thyroid cancer. As a targeted therapy, it works at a molecular level to slow cancer cell proliferation while sparing healthy tissue.
Composition: Sorafenib (200mg)
Manufacturer: Cipla Ltd
Prescription-only oncology medication. Use only under the direct supervision of a licensed oncologist. Regular blood tests and monitoring are mandatory throughout treatment.
Composition Sorafenib (200mg)
Dosage Form Tablets
Equivalent brand Nexavar
Generic Name Sorafenib
Indication Liver cancer, Kidney cancer, Thyroid cancer
Manufacturer Cipla Ltd
Packaging 120 tablets in 1 bottle
$250.00Price

